Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)

The summary for the Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional): The purpose of this Funding Opportunity Announcement (FOA) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.

Federal Grant Title:	Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-20-115
Type of Funding:	Grant
CFDA Numbers:	93.859
CFDA Descriptions:	Information not provided
Current Application Deadline:	May 27th, 2022
Original Application Deadline:	May 27th, 2022
Posted Date:	February 20th, 2020
Creation Date:	February 20th, 2020
Archive Date:	July 2nd, 2022
Total Program Funding:
Maximum Federal Grant Award:	$750,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	February 20th, 2020

Applicants Eligible for this Grant: Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See FOA for full eligibility details.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-20-115.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34); • Maximizing Access to Research Careers (MARC) (T34); • Medical Scientist Training Program (MSTP) (T32); • Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed); • Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial ...; • Tools for Genetic and Genomic Studies in Emerging Model Organisms; • Evolution of Infectious Diseases; • Mbrs Support of Continuous Research Excellence (Score)
More Grants from the National Institutes of Health: • NEI Research for Low Vision and Blindness Accessibility Tools (R61/R33 Clinical Trial Opti...; • Access and Manipulation of Brain Cell Subtypes Implicated in Aging and AD/ADRD (R61/R33 Cl...; • Nutrition Obesity Research Centers (P30 Clinical Trial Optional); • Nutrition Obesity Research Centers Research Resource Center (RRC) (P2C- Clinical Trial Opt...; • Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Tr...